These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37833938)

  • 21. Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1-42).
    Kim YM; Park S; Choi SY; Oh SB; Jung M; Pack CG; Hwang JJ; Tak E; Lee JY
    Mol Neurobiol; 2022 Oct; 59(10):6228-6244. PubMed ID: 35904715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
    De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
    J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.
    Levites Y; Das P; Price RW; Rochette MJ; Kostura LA; McGowan EM; Murphy MP; Golde TE
    J Clin Invest; 2006 Jan; 116(1):193-201. PubMed ID: 16341263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxylated Single-Walled Carbon Nanotubes Inhibit Aβ
    Liu F; Wang W; Sang J; Jia L; Lu F
    ACS Chem Neurosci; 2019 Jan; 10(1):588-598. PubMed ID: 30335950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity inhibitors protect lipid membranes from disruption by Aβ42.
    Malishev R; Nandi S; Kolusheva S; Levi-Kalisman Y; Klärner FG; Schrader T; Bitan G; Jelinek R
    ACS Chem Neurosci; 2015 Nov; 6(11):1860-9. PubMed ID: 26317327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
    Gu L; Guo Z
    J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.
    Stöhr J; Condello C; Watts JC; Bloch L; Oehler A; Nick M; DeArmond SJ; Giles K; DeGrado WF; Prusiner SB
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10329-34. PubMed ID: 24982137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease.
    Koppensteiner P; Trinchese F; Fà M; Puzzo D; Gulisano W; Yan S; Poussin A; Liu S; Orozco I; Dale E; Teich AF; Palmeri A; Ninan I; Boehm S; Arancio O
    Sci Rep; 2016 Sep; 6():32553. PubMed ID: 27581852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The accuracy and robustness of plasma biomarker models for amyloid PET positivity.
    Benedet AL; Brum WS; Hansson O; ; Karikari TK; Zimmer ER; Zetterberg H; Blennow K; Ashton NJ
    Alzheimers Res Ther; 2022 Feb; 14(1):26. PubMed ID: 35130933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with Alzheimer's disease have an increased removal rate of soluble beta-amyloid-42.
    Zaretsky DV; Zaretskaia MV; Molkov YI;
    PLoS One; 2022; 17(10):e0276933. PubMed ID: 36315527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of Isoflurane, Tumor Necrosis Factor-α and β-Amyloid on Long-term Potentiation in Rat Hippocampal Slices.
    Zhou R; Bickler P
    Anesth Analg; 2017 Feb; 124(2):582-587. PubMed ID: 28099324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
    Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J
    Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.
    Beach TG; Maarouf CL; Intorcia A; Sue LI; Serrano GE; Lu M; Joshi A; Pontecorvo MJ; Roher AE
    J Alzheimers Dis; 2018; 61(4):1509-1516. PubMed ID: 29376867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of Amyloid-β in Plasma by Simple and Highly Sensitive Immunoaffinity Enrichment and LC-MS/MS Assay.
    Iino T; Watanabe S; Yamashita K; Tamada E; Hasegawa T; Irino Y; Iwanaga S; Harada A; Noda K; Suto K; Yoshida T
    J Appl Lab Med; 2021 Jul; 6(4):834-845. PubMed ID: 33462584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonlinear and mixed inhibitory effect of matrine on the cytotoxicity of oligomeric amyloid-β protein.
    Yang B; Li H; Zhang T; Wang Z; Li H; Zhang Y
    Neurochem Int; 2020 Jul; 137():104746. PubMed ID: 32325190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurophysiologic responses of peripheral nerve to repeated episodes of anoxia.
    Stecker M; Wolfe J; Stevenson M
    Clin Neurophysiol; 2013 Apr; 124(4):792-800. PubMed ID: 23084661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.